Biotech News

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Option Care (OPCH)Option Care2026-06-04 11:00 ESTCompany update

BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.

Open original release

Related news

OPCHOption Care2026-06-01 11:00 EST

Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking

OPCHOption Care2026-05-04 20:05 EST

Option Care Health to Participate in the Bank of America Health Care Conference

OPCHOption Care2026-04-30 11:05 EST

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026

OPCHOption Care2026-04-08 20:05 EST

Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call

OPCHOption Care2026-02-24 12:00 EST

Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025

OPCHOption Care2026-01-29 21:05 EST

Option Care Health to Participate in the TD Cowen Healthcare Conference

OPCHOption Care2026-01-21 21:05 EST

Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call

OPCHOption Care2026-01-12 21:35 EST

Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026

OPCHOption Care2025-12-12 12:00 EST

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

OPCHOption Care2025-11-03 21:05 EST

Option Care Health to Participate in Upcoming Investor Conferences

View all latest news

Option Care

Option Care Health is the largest independent home infusion services company in the United States, delivering specialty infusion therapies outside the hospital.

Recent company news

OPCHBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

OPCHQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

OPCHMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

OPCHAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

OPCHGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close: 21.08 USD
Market cap: 3.23B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States